The county’s Human Services Committee today, on the advice of County Attorney Kevin Earl, recommended adoption of a resolution that would enable Genesee to participate in the New York Opioid Sharing Agreement.

The settlement, negotiated by New York Attorney General Letitia James, would provide Genesee County with a sum between $177,000 and $413,000, Earl said, with approximately half of the money to be "front-loaded" as an initial payment representing the first three years – possibly as soon as February 2022.

"It is my understanding that the balance will be paid over the next nine years on the state's remaining 10-year payments," he added.

Earl said the actual amount is on a sliding scale, depending upon the number of municipalities opting in.

He said there is a good chance that the county would get its full share of the settlement funds, which could be as high as $229 million to New York State.

The resolution passed by the HSC (which is subject to approval by the full legislature next week) alleges several causes of action against defendants Johnson & Johnson, and affiliates based on claims that J & J contributed to the opioid epidemic by falsely promoting prescription opioids it manufactured and sold and by falsely promoting the increased use of opioids directly and generally through various “front groups” and failing to implement measures to prevent diversion of prescription opioids in connection with distribution of its products, all of which contributed to a public health crisis in the County of Genesee.

As reported previously on The Batavian (see link below), Genesee County has retained the services of Napoli Shkolnik PLLC of New York City to litigate on its behalf. Earl said this firm and another based in New York City represent the vast majority of municipalities in New York State.

Earl said two other law suits are in the works – one against Pharma, maker of oxycontin, which has filed bankruptcy (reorganization) and the other against the distributors of these powerful drugs.

“That’s three potential bites of the apple (for the county),” he said.

Any funds received in the Johnson & Johnson case would have to be used in areas related to expenses incurred as a result of the opioid epidemic, Earl said, although “there is quite of bit of flexibility” in the guidelines.

Those uses would include treatment/support groups, prevention, training, first responders and research. Allocation of the funds is being coordinated by the NYS Office of Addiction Services and Supports.

Previously: GCASA director: Multimillion dollar deal with opioid distributors would 'stabilize' treatment system

Comment from Anne Constantino, president and CEO of Horizon Health Services, which has an office in Batavia:

“We are grateful to the Attorney General for her success in this settlement that will absolutely deliver much needed resources in our efforts to prevent, combat and treat the serious public health crisis of addiction.”

-----------------

The executive director of a local substance use prevention and treatment agency is hailing today’s announcement that four major pharmaceutical distributors are close to an agreement to pay out $26 billion to states and municipalities for their roles in perpetuating the nation’s opioid epidemic.

“Yes, this is welcome news and I’m just hoping the money ends up going to assist individuals and families struggling with opioid addiction,” said John Bennett, executive director of Genesee/Orleans Council on Alcoholism and Substance Abuse. “It definitely is needed to stabilize the treatment system that has been impacted negatively by the recent pandemic.”

According to multiple media outlets, Johnson & Johnson, Cardinal Health, McKesson and AmerisourceBergen are near a deal that would resolve multiple legal challenges as well as pay for prevention, treatment and recovery services throughout the United States.

Genesee County Attorney Kevin Earl said it will be awhile before it is known how much money will be allocated locally.

The New York City law firm of Napoli Shkolnik PLLC is representing Genesee County as well as several other counties, Earl said.

“Most of the particulars are up in the air right now,” Earl said. “The county has retained this law firm to represent us in the litigation and they have advised us of the settlement with three of the distributors and Johnson & Johnson, but it’s too early to tell what Genesee County or any other participant in the litigation will get.”

A published report in today’s online edition of The New York Times indicates that the pact has yet to be finalized and “could still fall apart or have significant changes.”

The Times’ story also included the following:

-- According to lawyers familiar with negotiations, Johnson & Johnson, which made an opioid painkiller and a fentanyl patch and supplied opium-based ingredients to other drug manufacturers, would pay $3.7 billion in the first three years and $1.3 billion over the next six years. It had already shut down its supply business and discontinued its opioids, and agreed to refrain from selling opioids.

-- The distributors as well as several manufacturers are in the midst of a trial in a case brought by the State of New York and two of its counties. This morning, Letitia James, the attorney general for New York, announced a $1.1 billion deal with the distributors to settle that case. That money would be a part of the overall $26 billion settlement, but so far, it is the only deal that has been formally agreed to. Payments to New York State could begin in two months, Ms. James said.

Genesee County Manager Matt Landers said he was “fairly certain” that the money awarded to the county is for specific purposes, unlike the tobacco settlement, which gave counties more leeway to use the money for general operations.

“This money would have to go towards specifically combatting opioids,” he said. “So, it would lead to us partnering with agencies in the community to help deliver these services – agencies such as GCASA and others.”

Marcus Molinaro, president of the New York State County Executives Association, said in a press release that the settlement “comes at a crucial moment as counties across the state and nation grapple with a startling resurgence in overdose deaths.”

“No amount of money can bring back the lives lost to the opioid epidemic, but it can honor those lost by investing in prevention, education and treatment services to save lives,” he said.

“New York’s county executives were proud to work in collaboration with Attorney General Letitia James to pass legislation creating an Opioid Settlement Fund to ensure those most responsible for plunging us into this crisis, and not local taxpayers, pay for treatment, recovery, and abatement efforts critical to defeating this deadly scourge.”

But, according to Paul Pettit, public health director of Genesee and Orleans counties, this development doesn’t negate the fact that less than a third of Genesee County citizens has been vaccinated.

“Only 31 percent of the county (has received the vaccine),” Pettit said at this afternoon’s Genesee County Legislature Human Services Committee meeting at the Old County Courthouse. “We’re lagging behind the rest of New York State and the Finger Lakes Region, but we’re closing that gap.”

Gov. Andrew Cuomo announced that beginning tomorrow, 16- and 17-year-olds can only get the Pfizer vaccine, while those 18 and older will be eligible to take the Pfizer, Johnson & Johnson or Moderna shot.

Pettit said he expects Tuesday to be a “big day” with the first dose of the Moderna COVID-19 vaccine (for those 18 and over) scheduled to be administered from 9 a.m. to 6 p.m. at Genesee Community College. As of 8:30 this evening, 18 appointments were available.

For more information, go to the GO Health website at G O Health COVID-19 Vaccination Schedule and Guidance – Orleans County Government (orleanscountyny.com).

The health director also said that the virus’ positivity rate in the county is “picking up a little bit, which is not unexpected.” He said the rate is at 2 percent in the Finger Lakes Region, up from 1.5 percent a couple of weeks ago.

He also noted that other strains of the coronavirus have been identified in Western New York – leading to more infections – and officials are seeing an increase in those in their 30s and 40s.

“Again, not unexpected as we have concentrated on vaccinating seniors,” Pettit said. “Once we focus on them (younger people), we will see those numbers go down. But there are still a lot of unvaccinated people.”

He continues to urge folks to wear face coverings and practice social distancing.

“Keep vigilant … stay the course,” he said, adding that all three vaccines have been proven to be effective in preventing the virus, reducing symptoms for those who do get it and, “most importantly, the vaccine prevents death.”

When asked about the Excelsior Pass, an app that enables people to prove that they have been vaccinated, Pettit said determining its expiration date is a work in progress – and is subject to statistical measurements.

“We’re not sure of how long the vaccine holds up and we only have eight months of data,” he said.

Pettit said that current recommendations call for a booster shot a year after the first vaccination, but that doesn’t consider new variants and strains.

“There will be a booster shot at some point,” he predicted.

In related action, the committee forwarded a resolution to the Ways & Means Committee to extend for another six months (through Dec. 31) two temporary positions to assist with the county’s response to the coronavirus – a full-time clerk typist and a full-time COVID-19 response specialist.

“This is necessary since we continue to provide vaccinations and testing,” Pettit said. “Hopefully, this will be the only extension we need.”

In other action, the committee granted permission to apply for a grant to help the health department prevent childhood lead poisoning and for surveillance of blood lead levels in children.

Funding of $1.1 million over five years from the Centers for Disease Control and Prevention will be awarded through cooperative agreements to support primary and secondary prevention strategies for childhood lead poisoning prevention and surveillance.

Strategies include ensuring blood lead testing and reporting; enhancing blood lead surveillance; improving linkages to recommended services; and developing policies for targeted, population-based interventions with a focus on community-based approaches for lead hazard elimination.

Calling it a “big challenge,” Petti said he expects lead poison testing to pick up as COVID subsides. Should the department receive the grant, he said another employee will be hired to assist with the large data component attached to the funding.